Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox

Transfusional Hemosiderosis Clinical Trial

Official title:
International Sentinel Site Surveillance of Patients With Transfusional Hemosiderosis Treated With Deferasirox in Actual Practice Setting

Status Completed

Clinical Trial Summary

This study will observe patients with transfusional hemosiderosis treated with deferasirox in actual practice setting.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01394029
Study type	Observational
Source	Novartis
Contact
Status	Completed
Phase	N/A
Start date	July 2011
Completion date	October 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00631163` - Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis	Phase 2
Completed	`NCT00600938` - Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload	Phase 2
Withdrawn	`NCT01927913` - Treatment of Iron Overload Requiring Chelation Therapy	Phase 2
Completed	`NCT00845871` - Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food	Phase 4